Copyright Reports & Markets. All rights reserved.

Cell and Gene Therapy Manufacturing QC-Global Market Status and Trend Report 2016-2026

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of Cell and Gene Therapy Manufacturing QC

    • 1.1 Definition of Cell and Gene Therapy Manufacturing QC in This Report
    • 1.2 Commercial Types of Cell and Gene Therapy Manufacturing QC
      • 1.2.1 Safety Testing
      • 1.2.2 Purity Testing
      • 1.2.3 Potency Testing
      • 1.2.4 Identity Testing
      • 1.2.5 Stability Testing
    • 1.3 Downstream Application of Cell and Gene Therapy Manufacturing QC
      • 1.3.1 Precision Therapy
      • 1.3.2 Biological Research
    • 1.4 Development History of Cell and Gene Therapy Manufacturing QC
    • 1.5 Market Status and Trend of Cell and Gene Therapy Manufacturing QC 2016-2026
      • 1.5.1 Global Cell and Gene Therapy Manufacturing QC Market Status and Trend 2016-2026
      • 1.5.2 Regional Cell and Gene Therapy Manufacturing QC Market Status and Trend 2016-2026

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of Cell and Gene Therapy Manufacturing QC 2016-2021
    • 2.2 Production Market of Cell and Gene Therapy Manufacturing QC by Regions
      • 2.2.1 Production Volume of Cell and Gene Therapy Manufacturing QC by Regions
      • 2.2.2 Production Value of Cell and Gene Therapy Manufacturing QC by Regions
    • 2.3 Demand Market of Cell and Gene Therapy Manufacturing QC by Regions
    • 2.4 Production and Demand Status of Cell and Gene Therapy Manufacturing QC by Regions
      • 2.4.1 Production and Demand Status of Cell and Gene Therapy Manufacturing QC by Regions 2016-2021
      • 2.4.2 Import and Export Status of Cell and Gene Therapy Manufacturing QC by Regions 2016-2021

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of Cell and Gene Therapy Manufacturing QC by Types
    • 3.2 Production Value of Cell and Gene Therapy Manufacturing QC by Types
    • 3.3 Market Forecast of Cell and Gene Therapy Manufacturing QC by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of Cell and Gene Therapy Manufacturing QC by Downstream Industry
    • 4.2 Market Forecast of Cell and Gene Therapy Manufacturing QC by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of Cell and Gene Therapy Manufacturing QC

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 Cell and Gene Therapy Manufacturing QC Downstream Industry Situation and Trend Overview

    Chapter 6 Cell and Gene Therapy Manufacturing QC Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of Cell and Gene Therapy Manufacturing QC by Major Manufacturers
    • 6.2 Production Value of Cell and Gene Therapy Manufacturing QC by Major Manufacturers
    • 6.3 Basic Information of Cell and Gene Therapy Manufacturing QC by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of Cell and Gene Therapy Manufacturing QC Major Manufacturer
      • 6.3.2 Employees and Revenue Level of Cell and Gene Therapy Manufacturing QC Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 Cell and Gene Therapy Manufacturing QC Major Manufacturers Introduction and Market Data

    • 7.1 Bio-Techne Corporation
      • 7.1.1 Company profile
      • 7.1.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.1.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Bio-Techne Corporation
    • 7.2 BioMerieux SA
      • 7.2.1 Company profile
      • 7.2.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.2.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of BioMerieux SA
    • 7.3 Catalent, Inc.
      • 7.3.1 Company profile
      • 7.3.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.3.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Catalent, Inc.
    • 7.4 Charles River Laboratories International Inc.
      • 7.4.1 Company profile
      • 7.4.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.4.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Charles River Laboratories International Inc.
    • 7.5 Eurofins Scientific SE
      • 7.5.1 Company profile
      • 7.5.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.5.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Eurofins Scientific SE
    • 7.6 F. Hoffmann-La Roche Ltd
      • 7.6.1 Company profile
      • 7.6.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.6.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
    • 7.7 Intertek Group plc
      • 7.7.1 Company profile
      • 7.7.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.7.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Intertek Group plc
    • 7.8 Lonza Group AG
      • 7.8.1 Company profile
      • 7.8.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.8.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Lonza Group AG
    • 7.9 Merck KGaA
      • 7.9.1 Company profile
      • 7.9.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.9.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Merck KGaA
    • 7.10 Sartorius AG
      • 7.10.1 Company profile
      • 7.10.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.10.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Sartorius AG
    • 7.11 SGS S.A.
      • 7.11.1 Company profile
      • 7.11.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.11.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of SGS S.A.
    • 7.12 Sistemic Scotland Limited
      • 7.12.1 Company profile
      • 7.12.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.12.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Sistemic Scotland Limited
    • 7.13 Thermo Fisher Scientific Inc.
      • 7.13.1 Company profile
      • 7.13.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.13.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
    • 7.14 Vigene Biosciences, Inc.
      • 7.14.1 Company profile
      • 7.14.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.14.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Vigene Biosciences, Inc.
    • 7.15 WuXi AppTec
      • 7.15.1 Company profile
      • 7.15.2 Representative Cell and Gene Therapy Manufacturing QC Product
      • 7.15.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of WuXi AppTec

    Chapter 8 Upstream and Downstream Market Analysis of Cell and Gene Therapy Manufacturing QC

    • 8.1 Industry Chain of Cell and Gene Therapy Manufacturing QC
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of Cell and Gene Therapy Manufacturing QC

    • 9.1 Cost Structure Analysis of Cell and Gene Therapy Manufacturing QC
    • 9.2 Raw Materials Cost Analysis of Cell and Gene Therapy Manufacturing QC
    • 9.3 Labor Cost Analysis of Cell and Gene Therapy Manufacturing QC
    • 9.4 Manufacturing Expenses Analysis of Cell and Gene Therapy Manufacturing QC

    Chapter 10 Marketing Status Analysis of Cell and Gene Therapy Manufacturing QC

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      Cell and Gene Therapy Manufacturing QC-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Cell and Gene Therapy Manufacturing QC industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of Cell and Gene Therapy Manufacturing QC 2016-2021, and development forecast 2022-2026
      Main manufacturers/suppliers of Cell and Gene Therapy Manufacturing QC worldwide, with company and product introduction, position in the Cell and Gene Therapy Manufacturing QC market
      Market status and development trend of Cell and Gene Therapy Manufacturing QC by types and applications
      Cost and profit status of Cell and Gene Therapy Manufacturing QC, and marketing status
      Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Cell and Gene Therapy Manufacturing QC market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Cell and Gene Therapy Manufacturing QC industry.

      The report segments the global Cell and Gene Therapy Manufacturing QC market as:

      Global Cell and Gene Therapy Manufacturing QC Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global Cell and Gene Therapy Manufacturing QC Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
      Safety Testing
      Purity Testing
      Potency Testing
      Identity Testing
      Stability Testing

      Global Cell and Gene Therapy Manufacturing QC Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
      Precision Therapy
      Biological Research

      Global Cell and Gene Therapy Manufacturing QC Market: Manufacturers Segment Analysis (Company and Product introduction, Cell and Gene Therapy Manufacturing QC Sales Volume, Revenue, Price and Gross Margin):
      Bio-Techne Corporation
      BioMerieux SA
      Catalent, Inc.
      Charles River Laboratories International Inc.
      Eurofins Scientific SE
      F. Hoffmann-La Roche Ltd
      Intertek Group plc
      Lonza Group AG
      Merck KGaA
      Sartorius AG
      SGS S.A.
      Sistemic Scotland Limited
      Thermo Fisher Scientific Inc.
      Vigene Biosciences, Inc.
      WuXi AppTec

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now